vs

Side-by-side financial comparison of ACNB CORP (ACNB) and MEDIFAST INC (MED). Click either name above to swap in a different company.

MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $47.2M, roughly 1.6× ACNB CORP). On growth, ACNB CORP posted the faster year-over-year revenue change (42.2% vs -36.9%). ACNB CORP produced more free cash flow last quarter ($52.6M vs $-6.6M). Over the past eight quarters, ACNB CORP's revenue compounded faster (22.1% CAGR vs -34.4%).

ACNB Corp is a US-based financial holding company headquartered in Pennsylvania. It provides a full suite of financial solutions including retail and commercial banking, wealth management, trust services, and property & casualty insurance products. Its core market covers local communities, individual consumers, and small-to-medium enterprises across south-central Pennsylvania and northern Maryland.

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

ACNB vs MED — Head-to-Head

Bigger by revenue
MED
MED
1.6× larger
MED
$75.1M
$47.2M
ACNB
Growing faster (revenue YoY)
ACNB
ACNB
+79.1% gap
ACNB
42.2%
-36.9%
MED
More free cash flow
ACNB
ACNB
$59.2M more FCF
ACNB
$52.6M
$-6.6M
MED
Faster 2-yr revenue CAGR
ACNB
ACNB
Annualised
ACNB
22.1%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACNB
ACNB
MED
MED
Revenue
$47.2M
$75.1M
Net Profit
$10.8M
Gross Margin
69.4%
Operating Margin
27.9%
-10.4%
Net Margin
22.9%
Revenue YoY
42.2%
-36.9%
Net Profit YoY
63.8%
EPS (diluted)
$1.10
$-1.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACNB
ACNB
MED
MED
Q4 25
$47.2M
$75.1M
Q3 25
$50.9M
$89.4M
Q2 25
$50.3M
$105.6M
Q1 25
$43.5M
$115.7M
Q4 24
$33.2M
$119.0M
Q3 24
$34.1M
$140.2M
Q2 24
$33.3M
$168.6M
Q1 24
$31.6M
$174.7M
Net Profit
ACNB
ACNB
MED
MED
Q4 25
$10.8M
Q3 25
$14.9M
$-2.3M
Q2 25
$11.6M
$2.5M
Q1 25
$-272.0K
$-772.0K
Q4 24
$6.6M
Q3 24
$7.2M
$1.1M
Q2 24
$11.3M
$-8.2M
Q1 24
$6.8M
$8.3M
Gross Margin
ACNB
ACNB
MED
MED
Q4 25
69.4%
Q3 25
69.5%
Q2 25
72.6%
Q1 25
72.8%
Q4 24
74.1%
Q3 24
75.4%
Q2 24
73.2%
Q1 24
72.8%
Operating Margin
ACNB
ACNB
MED
MED
Q4 25
27.9%
-10.4%
Q3 25
37.2%
-4.6%
Q2 25
29.7%
-1.0%
Q1 25
-1.3%
-1.1%
Q4 24
24.8%
0.6%
Q3 24
27.6%
1.5%
Q2 24
42.8%
-4.7%
Q1 24
26.9%
4.5%
Net Margin
ACNB
ACNB
MED
MED
Q4 25
22.9%
Q3 25
29.2%
-2.5%
Q2 25
23.2%
2.3%
Q1 25
-0.6%
-0.7%
Q4 24
19.9%
Q3 24
21.1%
0.8%
Q2 24
33.9%
-4.8%
Q1 24
21.4%
4.8%
EPS (diluted)
ACNB
ACNB
MED
MED
Q4 25
$1.10
$-1.64
Q3 25
$1.42
$-0.21
Q2 25
$1.11
$0.22
Q1 25
$-0.03
$-0.07
Q4 24
$0.77
$0.08
Q3 24
$0.84
$0.10
Q2 24
$1.32
$-0.75
Q1 24
$0.80
$0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACNB
ACNB
MED
MED
Cash + ST InvestmentsLiquidity on hand
$65.6M
$167.3M
Total DebtLower is stronger
$255.4M
Stockholders' EquityBook value
$420.0M
$198.9M
Total Assets
$3.2B
$248.0M
Debt / EquityLower = less leverage
0.61×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACNB
ACNB
MED
MED
Q4 25
$65.6M
$167.3M
Q3 25
$102.1M
$173.5M
Q2 25
$103.1M
$162.7M
Q1 25
$123.6M
$164.6M
Q4 24
$47.3M
$162.3M
Q3 24
$58.1M
$170.0M
Q2 24
$86.3M
$163.5M
Q1 24
$53.1M
$156.4M
Total Debt
ACNB
ACNB
MED
MED
Q4 25
$255.4M
Q3 25
$255.4M
Q2 25
$255.4M
Q1 25
$255.3M
Q4 24
$255.3M
Q3 24
$255.3M
Q2 24
$255.3M
Q1 24
$255.3M
Stockholders' Equity
ACNB
ACNB
MED
MED
Q4 25
$420.0M
$198.9M
Q3 25
$408.6M
$214.7M
Q2 25
$395.2M
$216.0M
Q1 25
$386.9M
$211.0M
Q4 24
$303.3M
$210.1M
Q3 24
$306.8M
$207.3M
Q2 24
$289.3M
$205.3M
Q1 24
$279.9M
$211.0M
Total Assets
ACNB
ACNB
MED
MED
Q4 25
$3.2B
$248.0M
Q3 25
$3.3B
$268.2M
Q2 25
$3.3B
$269.3M
Q1 25
$3.3B
$280.0M
Q4 24
$2.4B
$284.2M
Q3 24
$2.4B
$291.2M
Q2 24
$2.5B
$293.5M
Q1 24
$2.4B
$302.8M
Debt / Equity
ACNB
ACNB
MED
MED
Q4 25
0.61×
Q3 25
0.62×
Q2 25
0.65×
Q1 25
0.66×
Q4 24
0.84×
Q3 24
0.83×
Q2 24
0.88×
Q1 24
0.91×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACNB
ACNB
MED
MED
Operating Cash FlowLast quarter
$53.6M
$-5.3M
Free Cash FlowOCF − Capex
$52.6M
$-6.6M
FCF MarginFCF / Revenue
111.4%
-8.8%
Capex IntensityCapex / Revenue
2.3%
1.8%
Cash ConversionOCF / Net Profit
4.96×
TTM Free Cash FlowTrailing 4 quarters
$92.2M
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACNB
ACNB
MED
MED
Q4 25
$53.6M
$-5.3M
Q3 25
$23.2M
$12.1M
Q2 25
$17.8M
$-3.4M
Q1 25
$-71.0K
$3.4M
Q4 24
$39.8M
$-4.9M
Q3 24
$13.6M
$9.1M
Q2 24
$9.7M
$13.1M
Q1 24
$10.8M
$7.3M
Free Cash Flow
ACNB
ACNB
MED
MED
Q4 25
$52.6M
$-6.6M
Q3 25
$22.8M
$10.8M
Q2 25
$17.6M
$-4.8M
Q1 25
$-730.0K
$1.9M
Q4 24
$38.8M
$-7.2M
Q3 24
$13.3M
$7.7M
Q2 24
$9.4M
$11.1M
Q1 24
$10.7M
$5.4M
FCF Margin
ACNB
ACNB
MED
MED
Q4 25
111.4%
-8.8%
Q3 25
44.7%
12.0%
Q2 25
35.0%
-4.5%
Q1 25
-1.7%
1.6%
Q4 24
117.0%
-6.1%
Q3 24
39.1%
5.5%
Q2 24
28.3%
6.6%
Q1 24
33.9%
3.1%
Capex Intensity
ACNB
ACNB
MED
MED
Q4 25
2.3%
1.8%
Q3 25
0.8%
1.5%
Q2 25
0.4%
1.3%
Q1 25
1.5%
1.3%
Q4 24
2.9%
1.9%
Q3 24
0.7%
1.0%
Q2 24
0.9%
1.1%
Q1 24
0.2%
1.1%
Cash Conversion
ACNB
ACNB
MED
MED
Q4 25
4.96×
Q3 25
1.56×
Q2 25
1.52×
-1.36×
Q1 25
Q4 24
6.03×
Q3 24
1.88×
8.04×
Q2 24
0.86×
Q1 24
1.60×
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons